Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea

View source ↗

Summary

A completed clinical trial evaluated the safety and efficacy of Botulinum toxin type A (BOTOX) for treating chronic migraine in Korea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders, Headache | Status: COMPLETED